Excellence in Hemoglobinopathies Research Award ProjectFebruary 5, 2012
The National Institutes of Health, more typically called the NIH, is a federal government agency operating within the United States Department of Health and Human Services that’s suitably accountable for supporting the nation’s biomedical and health-related studies.
The programs and grants of the NIH are specially tailored to help in the accomplishment of its general agency mission which is to “seek fundamental knowledge on the nature and behaviour of living systems and the application of that knowledge to improve health, lengthen life, and reduce the burdens of sickness and disability.”
As per this mission, the National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute (NHLBI) in an attempt to develop the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that would possibly improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.
Initially, the NIH and the NHLBI will enter into a five-year cooperative agreement with the strongest candidate who has submitted a research proposal that could most likely develop therapeutic molecules, biomarkers, or imaging modalities in the study of hemoglobinopathies.
It’s the hope of the NHLBI that the proposals will pave the way to a few interdisciplinary approaches to translational research in the hemoglobinopathies, which comprises a higher likelihood of high-impact research eventually becoming applied clinical studies.
The end goal of the studies that will be proposed under this project are centered on the discovery of small molecules, biologics, and biomarkers that can all be used in the process of diagnosing, treating, and managing sickle cell illness or the thalassemias.
The NHLBI is willing to administer 7 to 10 grant awards with an overall budget of $72.85, with a total cost of $14 million for the year 2013 alone.
The organizations and establishments that’ll be deemed eligible to submit an application under the Excellence in Hemoglobinopathies Research Award Program are the following:
a) Higher Education Institutions such as Public/State Controlled Institutions of Higher Education and Private Institutions of Higher Education
b) Non-profits Other Than Institutions of Higher Education
c) For-Profit Organizations like Small Businesses and other setups apart from Small Businesses
d) State Governments, County Governments, City or Township Governments and Special District Governments
e) Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations (apart from Federally recognized tribal governments), Faith-based or Community-based Organizations, and Regional Organizations.
Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs.
He also maintains Websites providing resources on artist grants and children grants.